Respiratory Syncytial Virus Vaccine Development
- 3 November 2009
- journal article
- review article
- Published by Elsevier in Clinics In Laboratory Medicine
- Vol. 29 (4) , 725-739
- https://doi.org/10.1016/j.cll.2009.07.004
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus diseaseNature Medicine, 2008
- Sub-Nucleocapsid Nanoparticles: A Nasal Vaccine against Respiratory Syncytial VirusPLOS ONE, 2008
- Viral and Host Factors in Human Respiratory Syncytial Virus PathogenesisJournal of Virology, 2008
- Venezuelan Equine Encephalitis Virus Replicon Particles Encoding Respiratory Syncytial Virus Surface Glycoproteins Induce Protective Mucosal Responses in Mice and Cotton RatsJournal of Virology, 2007
- Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse modelVaccine, 2007
- Hepatitis B Surface Antigen Vector Delivers Protective Cytotoxic T-Lymphocyte Responses to Disease-Relevant Foreign EpitopesJournal of Virology, 2006
- Respiratory Syncytial Virus Infection in Elderly and High-Risk AdultsNew England Journal of Medicine, 2005
- Synthetic peptides corresponding to the F protein of RSV stimulate murine B and T cells but fail to confer protectionArchiv für die gesamte Virusforschung, 1991
- Evaluation in chimpanzees of vaccinia virus recombinants that express the surface glycoproteins of human respiratory syncytial virusVaccine, 1990
- Parenteral Administration of Live Respiratory Syncytial Virus Vaccine: Results of a Field TrialThe Journal of Infectious Diseases, 1982